CAT-1004 (Catabasis) Clinical Trial Webinar [May 2015] On May 13, 2015, Dr. Joanne Donovan, Chief Medical Officer at Catabasis Pharmaceuticals, presented information about MoveDMD: an upcoming Phase 1/2 clinical trial with CAT-1004 in boys with Duchenne muscular dystrophy. Research & Clinical Trial Webinars,Webinars 10 years ago You may also like 1:01:40 Webinar: RGX-202 – AFFINITY DUCHENNE Pivotal Program and Functional Data 3 weeks ago Research & Clinical Trial Webinars,Webinars gene therapy,RGX-202 51:49 Webinar: INSPIRE DUCHENNE Clinical Trial Update and Study Expansion 4 weeks ago Research & Clinical Trial Webinars,Webinars sgt-003,solid biosciences 56:19 Webinar: Exploring Muscle Regeneration – A New Approach with Satellos 1 month ago Research & Clinical Trial Webinars,Webinars 44:01 World Muscle Society 2024: CIFFREO Data Discussion with Pfizer 2 months ago Research & Clinical Trial Webinars,Webinars fordadistrogene movaparvovec,pfizer 59:49 Webinar: SHIELD DMD – A Bone Health Study in Duchenne 2 months ago Research & Clinical Trial Webinars,Webinars satralizumab 43:40 Webinar: Interim Results from FORWARD-53 Study of WVE-N531 in Duchenne Muscular Dystrophy 2 months ago Research & Clinical Trial Webinars,Webinars wave life sciences,WVE-N531 51:42 Webinar: Overview of DUVYZAT and Access Resources (September 2024) 3 months ago Research & Clinical Trial Webinars,Webinars 1:04:54 Webinar: Advocating for A Successful School Year (September 2024) 3 months ago Care Webinars,Webinars 123…25»Page 1 of 25
by: Parent Project Muscular Dystrophy
